RGD Peptide–Albumin Conjugate for Endothelization of Electrospun Materials


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

To improve the endothelization of 3D matrices produced by electrospinning we propose adding cyclo(RGDfC) peptide conjugated to human serum albumin (HSA) (HSA-c(RGDfC)) to the electrospinning solution. HSA-c(RGDfC) has been prepared using a bifunctional linker with N-hydroxysuccinimide and maleimide groups, and the product has been confirmed by 1Н NMR spectroscopy. Electrospun matrices have been fabricated from the solutions of 3% polyurethane Tecoflex EG-80A with 10% HSA and 0.01–1.3% HSA–c(RGDfC) (relative to Tec) in 1,1,1,3,3,3-hexafluoro-2-propanol. The presence of HSA and the cyclo(RGDfC) peptide on the surface of electrospun matrices has been confirmed by FTIR spectroscopy. The structure of matrices has been examined by scanning electron microscopy. The ability of the matrices to facilitate the adhesion of primary human umbilical vein endotheliocytes (HUVECs) has been studied. The presence of HSA–c(RGDfC) conjugate in the matrices enhanced cellular adhesion in a dose dependent manner with a maximum effect at 1% HSA-c(RGDfC).

Об авторах

A. Cherepanova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Автор, ответственный за переписку.
Email: a_cher@niboch.nsc.ru
Россия, Novosibirsk, 630090; Novosibirsk, 630055

D. Akisheva

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences

Email: a_cher@niboch.nsc.ru
Россия, Novosibirsk, 630090

T. Popova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
Россия, Novosibirsk, 630090; Novosibirsk, 630090

B. Chelobanov

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
Россия, Novosibirsk, 630090; Novosibirsk, 630090

Yu. Chesalov

Boreskov Institute of Catalysis, Federal Research Center, Siberian Branch, Russian Academy of Sciences

Email: a_cher@niboch.nsc.ru
Россия, Novosibirsk, 630090

T. Godovikova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
Россия, Novosibirsk, 630090; Novosibirsk, 630090

A. Karpenko

Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: a_cher@niboch.nsc.ru
Россия, Novosibirsk, 630055

P. Laktionov

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: a_cher@niboch.nsc.ru
Россия, Novosibirsk, 630090; Novosibirsk, 630055


© Pleiades Publishing, Ltd., 2019

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах